Cargando…

Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease

The majority of human coccidioidomycosis infections are asymptomatic or self-limited but may have sequestered spherules in highly structured granulomas. Under immunosuppression, reactivation of fungal growth can result in severe disease. B6D2F1 mice asymptomatically infected with C. posadasii strain...

Descripción completa

Detalles Bibliográficos
Autores principales: Shubitz, Lisa F., Powell, Daniel A., Dial, Sharon M., Butkiewicz, Christine D., Trinh, Hien T., Hsu, Amy P., Buntzman, Adam, Frelinger, Jeffrey A., Galgiani, John N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605249/
https://www.ncbi.nlm.nih.gov/pubmed/36294555
http://dx.doi.org/10.3390/jof8100991
_version_ 1784818019278520320
author Shubitz, Lisa F.
Powell, Daniel A.
Dial, Sharon M.
Butkiewicz, Christine D.
Trinh, Hien T.
Hsu, Amy P.
Buntzman, Adam
Frelinger, Jeffrey A.
Galgiani, John N.
author_facet Shubitz, Lisa F.
Powell, Daniel A.
Dial, Sharon M.
Butkiewicz, Christine D.
Trinh, Hien T.
Hsu, Amy P.
Buntzman, Adam
Frelinger, Jeffrey A.
Galgiani, John N.
author_sort Shubitz, Lisa F.
collection PubMed
description The majority of human coccidioidomycosis infections are asymptomatic or self-limited but may have sequestered spherules in highly structured granulomas. Under immunosuppression, reactivation of fungal growth can result in severe disease. B6D2F1 mice asymptomatically infected with C. posadasii strain 1038 were immunosuppressed with dexamethasone (DXM) in drinking water. Treated mice died 16–25 days later, while untreated mice survived (p < 0.001). Flow cytometry of lung granulomas on days 5, 10, 15, and 20 of DXM treatment showed immune cell populations decreased 0.5–1 log compared with untreated mice though neutrophils and CD19(+)IgD(−)IgM(−) cells rebounded by day 20. Histopathology demonstrated loss of granuloma structure by day 5 and increasing spherules through day 20. On day 20, T-cells were nearly absent and disorganized pyogranulomatous lesions included sheets of plasma cells and innumerable spherules. Mice given DXM for 14 days then stopped (DXM stop) survived 6 weeks (9/10). Lung fungal burdens were significantly lower (p = 0.0447) than mice that continued treatment (DXM cont) but higher than untreated mice. Histopathologically, DXM stop mice did not redevelop controlled granulomas by sacrifice, though T-cells were densely scattered throughout the lesions. This demonstrates a mouse model suitable for further study to understand the immunologic components responsible for maintenance control of coccidioidomycosis.
format Online
Article
Text
id pubmed-9605249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96052492022-10-27 Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease Shubitz, Lisa F. Powell, Daniel A. Dial, Sharon M. Butkiewicz, Christine D. Trinh, Hien T. Hsu, Amy P. Buntzman, Adam Frelinger, Jeffrey A. Galgiani, John N. J Fungi (Basel) Article The majority of human coccidioidomycosis infections are asymptomatic or self-limited but may have sequestered spherules in highly structured granulomas. Under immunosuppression, reactivation of fungal growth can result in severe disease. B6D2F1 mice asymptomatically infected with C. posadasii strain 1038 were immunosuppressed with dexamethasone (DXM) in drinking water. Treated mice died 16–25 days later, while untreated mice survived (p < 0.001). Flow cytometry of lung granulomas on days 5, 10, 15, and 20 of DXM treatment showed immune cell populations decreased 0.5–1 log compared with untreated mice though neutrophils and CD19(+)IgD(−)IgM(−) cells rebounded by day 20. Histopathology demonstrated loss of granuloma structure by day 5 and increasing spherules through day 20. On day 20, T-cells were nearly absent and disorganized pyogranulomatous lesions included sheets of plasma cells and innumerable spherules. Mice given DXM for 14 days then stopped (DXM stop) survived 6 weeks (9/10). Lung fungal burdens were significantly lower (p = 0.0447) than mice that continued treatment (DXM cont) but higher than untreated mice. Histopathologically, DXM stop mice did not redevelop controlled granulomas by sacrifice, though T-cells were densely scattered throughout the lesions. This demonstrates a mouse model suitable for further study to understand the immunologic components responsible for maintenance control of coccidioidomycosis. MDPI 2022-09-21 /pmc/articles/PMC9605249/ /pubmed/36294555 http://dx.doi.org/10.3390/jof8100991 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shubitz, Lisa F.
Powell, Daniel A.
Dial, Sharon M.
Butkiewicz, Christine D.
Trinh, Hien T.
Hsu, Amy P.
Buntzman, Adam
Frelinger, Jeffrey A.
Galgiani, John N.
Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
title Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
title_full Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
title_fullStr Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
title_full_unstemmed Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
title_short Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
title_sort reactivation of coccidioidomycosis in a mouse model of asymptomatic controlled disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605249/
https://www.ncbi.nlm.nih.gov/pubmed/36294555
http://dx.doi.org/10.3390/jof8100991
work_keys_str_mv AT shubitzlisaf reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease
AT powelldaniela reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease
AT dialsharonm reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease
AT butkiewiczchristined reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease
AT trinhhient reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease
AT hsuamyp reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease
AT buntzmanadam reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease
AT frelingerjeffreya reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease
AT galgianijohnn reactivationofcoccidioidomycosisinamousemodelofasymptomaticcontrolleddisease